Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
First Advantage Corporation (FA)
Sprinklr, Inc. (CXM)
Coliseum Acquisition (MITAU)
Upcoming IPO
Soulgate Inc. (SSR)
Bright Health Group Inc. (BHG)
Doximity, Inc. (DOCS)
Miromatrix Medical, Inc (MIRO)
Confluent, Inc. (CFLT)
Monte Rosa Therapeutics Inc. (GLUE)
Amtd Digital, Inc. (HKD)
Unicycive Therapeutics Inc. (UNCY)
Acurx Pharmaceuticals (ACXP)
Mister Car Wash, Inc. (MCW)
Elevation Oncology, Inc. (ELEV)
Alpha Teknova, Inc. (TKNO)
Gh Research Plc (GHRS)
Graphite Bio, Inc. (GRPH)
The Glimpse Group (VRAR)
Integral Ad Science Holding Corp. (IAS)
D-MARKET Electronic Services & Trading (HEPS)
Missfresh Limited (MF)
Dingdong (cayman) Limited (DDL)
Xometry, Inc. (XMTR)
Sentinelone, Inc. (S)
Intapp, Inc. (INTA)
Cvrx, Inc. (CVRX)
Legalzoom.com, Inc. (LZ)
Clear Secure, Inc. (YOU)
Torrid Holdings, Inc. (CURV)
D-market Electronic Services & Trading (HBX)
Evercommerce Inc (EVCM)
Krispy Kreme, Inc. (DNUT)
Priced IPO
Full Truck Alliance Co. Ltd. (YMM)
Century Therapeutics, Inc (IPSC)
Atai Life Sciences B.v. (ATAI)
Femasys (FEMY)
Tremor International Ltd. (TRMR)
Cyteir Therapeutics, Inc. (CYT)
Codex Dna, Inc. (DNAY)
Aihuishou International Co. Ltd. (RERE)
Ambrx Biopharma Inc (AMAM)
iSpecimen (ISPC)
Angel Oak Mortgage, Inc. (AOMR)
Lyell Immunopharma, Inc. (LYEL)
Verve Therapeutics, Inc. (VERV)
Molecular Partners Inc. (MOLN)
Walkme Ltd. (WKME)
Convey Holding Parent, Inc. (CNVY)
Alzamend Neuro (ALZN)
Taskus, Inc. (TASK)
Janux Therapeutics, Inc. (JANX)
Kanzhun Limited (BZ)
More companies

Talaris Therapeutics, Inc. (TALS)

Sector - Healthcare

Price chart

-9.12%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a late-clinical stage, cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation (allo-HSCT) that they believe has the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe non-malignant blood, immune and metabolic disorders. In the organ transplant setting, which is their initial focus, they believe their proprietary therapeutic approach, which they call Facilitated Allo-HSCT Therapy, could prevent organ rejection without the morbidity and mortality that has been associated with the use of lifelong anti-rejection medicines, also known as chronic immunosuppression. Beyond the organ transplant setting, their Facilitated Allo-HSCT Therapy also has the potential to treat a range of severe autoimmune diseases and severe non-malignant blood, immune and metabolic disorders, in each case with potential for similar outcomes to what has previously been observed with HSCT, while mitigating the toxicities, morbidities and extended hospital stay associated with the conditioning regimen typically required by HSCT. They believe that their target indications, individually and collectively, represent a significant unmet need and commercial opportunity.
Industry
Biological Products (no Diagnostic Substances)
CEO CFO
Scott Requadt Mary Kay Fenton
Employees Founded
82 2002

Contacts

Address: 570 S. Preston St Louisville, Ky 40202

Telephone: (502) 398-9250

Web page: http://www.talaristx.com

IPO information

First Trade Date 5/7/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 8.8
Shares Revised (MM) 8.8
Expected offer amount (MM) $149.6
Realized offer amount(MM) $149.6

Financial Data (last reporting year)

Market Cap (MM) $681.53
Revenues (MM) $0
Net Income (Loss) (MM) $-22.7

Voting

What do you think will happen with the TALS share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Morgan Stanley

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Morgan Stanley/ SVB Leerink/ Evercore ISI/ Guggenheim Securities
CO-Managers

Sector: Healthcare

Tweets about $TALS

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats